Veterans Administration Contracts with Boston Scientific for Cardiac Care Supplies

Recommended Sources

About Government Industry

BNET Government provides daily industry trends and global news coverage with insights for managers and executives within the world wide business of government contracting. We analyze new and interesting contract awards, government policy changes, and the trends in procurements and spending. There will also be discussions of the sector with a focus on small and innovative companies and business lines. The world's governments spend billions each year on a variety of hardware and services and the site will discuss how the money is being allocated.

In a press release on PR Newswire Boston Scientific announces that is has won a one year contract with four option years to provide its products the the U.S Veterans Administration. The initial contract value was not announced. Boston Scientific manufactures a variety of devices to treat cardiac problems such as stents, pacemakers and defibrillators. The VA will utilize their pacemakers and defibrillators to treat veterans with heart issues. The VA has gone through swings of the number of patients it has had to treat with the World War II generation of servicemen now declining but the number of Iraqi Freedom and Enduring Freedom veterans increasing. The Bush Administration substantially increased the VA budget and the new Obama one will do so as well. The VA buy services and supplies from a large number of businesses large and small as well as operating a great number of facilities with thousands of employees.

Tags: Boston Scientific Corp., Administration, VA, Public Relations, Workforce Management, Marketing, Corporate Communications, Human Resources, Matthew Potter

Matthew Potter works supporting US Army aviation programs. He holds degrees in history as well as studying at the Defense Acquisition University. He has written for Seeking Alpha and at his own website, Defense Procurement News.

BNET User Analysis

Voice your 2cents

Web Buzz:

Boston Scientific touts Taxus stents' cost-effectiveness

MarketWatch - 239 days 18 hours 45 minutes ago

WASHINGTON (MarketWatch) -- Results of one-year data compiled in Boston Scientific Corp.'s Syntax trial show that implanting its Taxus Express2 drug-coated stents is more effective for some people suffering from complex coronary artery disease than undergoing artery bypass graft surgery, the company announced. "Previously published Syntax data...
Boston Scientific profit rises 61%

MarketWatch - 126 days 9 hours 18 minutes ago

Boston Scientific second-quarter profit rises as the medical device maker posts double-digit growth in sales of both its cardiac rhythm management products and stents.
Whistleblower chirps on medical device makers

Schwitzer - 131 days 10 hours 9 minutes ago

"A federal judge has unsealed whistleblower lawsuits alleging that Boston Scientific, Medtronic, St. Jude Medical and four other manufacturers engaged in Medicare fraud by selling medical devices used during a heart procedure called surgical ablation," according to a story by Christopher Snowbeck of the St. Paul Pioneer Press. Further...
Watchdog blasts FDA on loose test compliance policy

Government Executive - 278 days 9 hours 16 minutes ago

The independent watchdog group Project on Government Oversight revealed Wednesday that top Food and Drug Administration medical-device officials backed off on a requirement that device manufacturers test their products according to federal standards -- the very standards put into place 30 years ago after a prominent lab provided fake data to...
Will Nevo Revive J&J’s Stent Business?

WSJ Health Blog - 188 days 15 hours 28 minutes ago

Johnson & Johnson released preliminary data from a study that compared its Nevo stent against a device made by Boston Scientific